Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing Dialysis

Sharon P. Andreoli, Jerry M. Bergstein, Donald J. Sherrard

Research output: Contribution to journalArticle

242 Citations (Scopus)

Abstract

Aluminum intoxication developed in three infants with azotemia who were not undergoing dialysis and who had been treated with aluminum hydroxide from the first month of life. Biopsies of the iliac crest demonstrated the presence of severe osteomalacia and massive deposition of aluminum in the bone. Serum aluminum levels were significantly (P<0.001) higher in these 3 infants and in 1 other, all of whom received more than 100 mg of elemental aluminum per kilogram of body weight per day (mean ± SD., 371.0 ± 178.9 ng per millileter [13.75 ± 6.6 μmol per liter]) than they were in 8 older children with azotemia who were not undergoing dialysis and who received less than 100 mg of elemental aluminum per kilogram per day (27.0 ± 18.6 ng per milliliter [1.0 ± 0.68 μmol per liter]), 7 such children who did not receive aluminum hydroxide (20.28 ± 9.2 ng per milliliter [0.75 ± 0.34 μmol per liter]), and 16 children with normal renal function (21.04 ± 4.9 ng per milliliter [0.78 ± 0.18 μmol per liter]). In all the children with azotemia who were treated with aluminum hydroxide, there was a positive correlation (r = 0.90: P<0.01) between the serum aluminum level and the daily dose of elemental aluminum. These studies indicate that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.

Original languageEnglish (US)
Pages (from-to)1079-1084
Number of pages6
JournalNew England Journal of Medicine
Volume310
Issue number17
DOIs
StatePublished - Apr 26 1984

Fingerprint

Azotemia
Aluminum
Dialysis
Aluminum Hydroxide
aluminum phosphate
Osteomalacia
Serum
Body Weight
Kidney
Biopsy
Bone and Bones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing Dialysis. / Andreoli, Sharon P.; Bergstein, Jerry M.; Sherrard, Donald J.

In: New England Journal of Medicine, Vol. 310, No. 17, 26.04.1984, p. 1079-1084.

Research output: Contribution to journalArticle

@article{68103e6539e04bc08a48988e310e3b7c,
title = "Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing Dialysis",
abstract = "Aluminum intoxication developed in three infants with azotemia who were not undergoing dialysis and who had been treated with aluminum hydroxide from the first month of life. Biopsies of the iliac crest demonstrated the presence of severe osteomalacia and massive deposition of aluminum in the bone. Serum aluminum levels were significantly (P<0.001) higher in these 3 infants and in 1 other, all of whom received more than 100 mg of elemental aluminum per kilogram of body weight per day (mean ± SD., 371.0 ± 178.9 ng per millileter [13.75 ± 6.6 μmol per liter]) than they were in 8 older children with azotemia who were not undergoing dialysis and who received less than 100 mg of elemental aluminum per kilogram per day (27.0 ± 18.6 ng per milliliter [1.0 ± 0.68 μmol per liter]), 7 such children who did not receive aluminum hydroxide (20.28 ± 9.2 ng per milliliter [0.75 ± 0.34 μmol per liter]), and 16 children with normal renal function (21.04 ± 4.9 ng per milliliter [0.78 ± 0.18 μmol per liter]). In all the children with azotemia who were treated with aluminum hydroxide, there was a positive correlation (r = 0.90: P<0.01) between the serum aluminum level and the daily dose of elemental aluminum. These studies indicate that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.",
author = "Andreoli, {Sharon P.} and Bergstein, {Jerry M.} and Sherrard, {Donald J.}",
year = "1984",
month = "4",
day = "26",
doi = "10.1056/NEJM198404263101704",
language = "English (US)",
volume = "310",
pages = "1079--1084",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing Dialysis

AU - Andreoli, Sharon P.

AU - Bergstein, Jerry M.

AU - Sherrard, Donald J.

PY - 1984/4/26

Y1 - 1984/4/26

N2 - Aluminum intoxication developed in three infants with azotemia who were not undergoing dialysis and who had been treated with aluminum hydroxide from the first month of life. Biopsies of the iliac crest demonstrated the presence of severe osteomalacia and massive deposition of aluminum in the bone. Serum aluminum levels were significantly (P<0.001) higher in these 3 infants and in 1 other, all of whom received more than 100 mg of elemental aluminum per kilogram of body weight per day (mean ± SD., 371.0 ± 178.9 ng per millileter [13.75 ± 6.6 μmol per liter]) than they were in 8 older children with azotemia who were not undergoing dialysis and who received less than 100 mg of elemental aluminum per kilogram per day (27.0 ± 18.6 ng per milliliter [1.0 ± 0.68 μmol per liter]), 7 such children who did not receive aluminum hydroxide (20.28 ± 9.2 ng per milliliter [0.75 ± 0.34 μmol per liter]), and 16 children with normal renal function (21.04 ± 4.9 ng per milliliter [0.78 ± 0.18 μmol per liter]). In all the children with azotemia who were treated with aluminum hydroxide, there was a positive correlation (r = 0.90: P<0.01) between the serum aluminum level and the daily dose of elemental aluminum. These studies indicate that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.

AB - Aluminum intoxication developed in three infants with azotemia who were not undergoing dialysis and who had been treated with aluminum hydroxide from the first month of life. Biopsies of the iliac crest demonstrated the presence of severe osteomalacia and massive deposition of aluminum in the bone. Serum aluminum levels were significantly (P<0.001) higher in these 3 infants and in 1 other, all of whom received more than 100 mg of elemental aluminum per kilogram of body weight per day (mean ± SD., 371.0 ± 178.9 ng per millileter [13.75 ± 6.6 μmol per liter]) than they were in 8 older children with azotemia who were not undergoing dialysis and who received less than 100 mg of elemental aluminum per kilogram per day (27.0 ± 18.6 ng per milliliter [1.0 ± 0.68 μmol per liter]), 7 such children who did not receive aluminum hydroxide (20.28 ± 9.2 ng per milliliter [0.75 ± 0.34 μmol per liter]), and 16 children with normal renal function (21.04 ± 4.9 ng per milliliter [0.78 ± 0.18 μmol per liter]). In all the children with azotemia who were treated with aluminum hydroxide, there was a positive correlation (r = 0.90: P<0.01) between the serum aluminum level and the daily dose of elemental aluminum. These studies indicate that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.

UR - http://www.scopus.com/inward/record.url?scp=0021240171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021240171&partnerID=8YFLogxK

U2 - 10.1056/NEJM198404263101704

DO - 10.1056/NEJM198404263101704

M3 - Article

C2 - 6708989

AN - SCOPUS:0021240171

VL - 310

SP - 1079

EP - 1084

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -